Researchers from University of Science and Technology of China (Hefei) have constructed a protein made up of anti-CD16, -IL-15, and -CD19 motifs, specifically designed to capture CD19-positive cancer cells and redirect them to natural killer (NK) cells. Credit: Cancer Biology & Medicine


Handcuffing the culprit cancer: Immunotherapy for cold tumors with trispecific antibody


Leave A Reply